• Pharmacokinetics of Temafloxacin: Implications for Antimicro

  2026-04-23

  This review of temafloxacin’s pharmacokinetics highlights its high oral bioavailability, extensive tissue distribution, and long elimination half-life, supporting convenient single or twice-daily dosing. The insights inform rational dosing strategies in antimicrobial therapy and provide a comparative context for evaluating related antibiotics such as Sulfamonomethoxine.

• miR-18a/ALOXE3 Axis Regulates Ferroptosis and Migration in G

  2026-04-23

  This study uncovers how miR-18a promotes glioblastoma by downregulating ALOXE3, which diminishes ferroptotic cell death and enhances tumor cell migration via 12-HETE signaling. These findings provide mechanistic insight into lipid metabolic regulation in GBM and suggest potential targets for future therapeutic strategies.

• Live-Dead Cell Staining Kit: Technical Guide for Reliable As

  2026-04-22

  The Live-Dead Cell Staining Kit (K2081) enables precise discrimination of live and dead cells in cultured populations, addressing a core challenge in viability and cytotoxicity assays. This kit is optimal for fluorescence-based workflows in research but should not be used in diagnostic or medical applications.

• RITA (NSC 652287): Precision Tool for Renal Carcinoma Workfl

  2026-04-22

  RITA (NSC 652287) is a selective MDM2-p53 interaction inhibitor that delivers nanomolar potency and robust tumor regression in renal carcinoma models. This guide translates the latest in vitro cancer drug evaluation methods into actionable workflows, troubleshooting strategies, and protocol enhancements for maximizing RITA's impact in apoptosis and tumor xenograft research.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Oxidative S

  2026-04-21

  The Lipid Peroxidation (MDA) Assay Kit from APExBIO empowers researchers to quantify malondialdehyde with exceptional sensitivity and reproducibility across biological matrices. With dual colorimetric and fluorescence readout, it advances oxidative stress biomarker discovery and translational studies, especially in the context of ferroptosis and therapeutic resistance.

• Diclofenac in Intestinal Organoid-Based Pharmacokinetic Assa

  2026-04-21

  Explore how Diclofenac, a non-selective COX inhibitor, enables advanced pharmacokinetic and inflammation research using human intestinal organoids. This article uniquely bridges compound characterization with practical assay guidance.

• RNA Pol II Inhibition Triggers Apoptosis via Loss of Pol IIA

  2026-04-20

  Harper et al. (2025) demonstrate that cell death from RNA Pol II inhibition results from the loss of hypophosphorylated RNA Pol IIA, not from passive mRNA decay as previously thought. This mechanistic insight reshapes our understanding of apoptosis in response to transcriptional blockade and suggests new directions for cancer therapy research.

• Tropisetron Hydrochloride: Precision Tools for 5-HT3 Pathway

  2026-04-20

  Explore the advanced utility of Tropisetron Hydrochloride as a selective 5-HT3 receptor antagonist in neuroscience receptor modulation and transporter interaction studies. This article offers a uniquely practical, assay-focused perspective on optimizing serotonin receptor signaling research.

• Scenario-Driven Solutions with Dihydroethidium (DHE, SKU C38

  2026-04-19

  This article delivers practical, evidence-based guidance for biomedical researchers using Dihydroethidium (DHE, SKU C3807) as a robust probe for superoxide detection and oxidative stress assays. Drawing on real laboratory scenarios, we illustrate how DHE enables sensitive, reproducible intracellular reactive oxygen species measurement and data interpretation in apoptosis, cardiovascular, and cancer research.

• A Unified Protocol for mRNA LNP Formulation and Evaluation

  2026-04-18

  Ma et al. present a comprehensive, stepwise protocol for the formulation, characterization, and evaluation of mRNA lipid nanoparticles (LNPs), lowering technical barriers for new entrants to the field. Their workflow integrates microfluidic mixing, robust physicochemical characterization, and both in vitro and in vivo testing, streamlining the experimental process for diverse mRNA delivery applications.

• HyperScribe™ T7 Kit for High-Yield RNA in Gene Editing Workf

  2026-04-17

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit streamlines high-yield in vitro RNA production for CRISPR gene editing. This article reveals workflow-critical insights and practical advances not covered elsewhere.

• S63845 MCL1 Inhibitor: Precision Tools for Apoptosis Researc

  2026-04-16

  S63845 is redefining apoptosis research as a highly selective, nanomolar-potent MCL1 inhibitor, enabling direct activation of the mitochondrial apoptotic pathway in hematological cancer models. This article details robust protocols, advanced use-cases, and troubleshooting strategies for leveraging S63845 in high-impact cancer research workflows.

• Machine Learning-Guided Discovery of Senolytics: Study Insig

  2026-04-15

  This article analyzes the 2023 Nature Communications study that applied machine learning to identify novel senolytic compounds capable of selectively eliminating senescent cells. The findings demonstrate that AI-driven approaches can efficiently accelerate senolytic discovery, with implications for cancer, aging, and translational research workflows.

• Macrophage-EV miR-660 Drives Breast Cancer Metastasis via KL

  2026-04-14

  This study uncovers how tumor-associated macrophages (TAMs) promote breast cancer progression by transferring extracellular vesicle (EV)-enclosed microRNA-660 to tumor cells, suppressing KLHL21 and activating the NF-κB pathway. These findings identify a novel mechanism of metastatic regulation and suggest new targets for therapeutic intervention in aggressive breast cancer.

• DMH1: ALK2 Inhibitor Workflow Advances for Organoid & NSCLC

  2026-04-13

  DMH1 stands out as a selective ALK2 inhibitor that empowers both organoid engineering and non-small cell lung cancer research with precise BMP pathway control. This guide details experimental workflows, troubleshooting insights, and protocol optimizations to maximize the impact of DMH1 in cutting-edge research applications.

442 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page